Re-estimates the synthetic control after artificially backdating the
treatment to a pre-treatment period, following Abadie, Diamond &
Hainmueller (2015) and Abadie & Vives-i-Bastida (2022, principle 7:
"out-of-sample validation is key"). Only pre-treatment data enter the
exercise, so the placebo gap after t0_placebo is uncontaminated by the
actual intervention. A credible design shows no sizable divergence at the
backdated treatment time.
Arguments
- fit
A sharp
coresynthobject fromscm_fit()withmethod = "scm".- t0_placebo
Backdated treatment period as a 1-based position in
fit$times; must satisfy2 <= t0_placebo < T_pre. Defaultfloor(T_pre / 2).
Value
A list with:
t0_placebo: the backdated treatment period usedtimes: time values of the pre-treatment windowunit_weights: placebo donor weightsY_treat,Y_synth,gap: series over the pre-treatment windowplacebo_att: mean placebo gap over(t0_placebo, T_pre]fit_rmspe: RMSPE over the placebo fitting window1..t0_placeboeval_rmspe: RMSPE over the placebo post window(t0_placebo, T_pre]
Details
The refit uses the outcomes of periods 1..t0_placebo as predictors
(the predictors = NULL default), regardless of how the original fit was
specified, because user-supplied pred() windows cannot be lagged
automatically (ADH 2015 lag their predictors by hand).
See also
mspe_ratio_pval() for in-space placebos, loo_donors() for
donor-robustness checks.
